Skip to main content

Lupus

      Virtual EULAR 2020 Round Up
      In this week's podcast, Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting held June 3-6, 2020. Featured reports include: SELECT-CHOICE study. ABA vs. UPA in…
      Autoinflammatory/Still's Disease Panel - EULAR2020

      Drs. Olga Petryna, Petros Efthimiou, Apostolos Kontzias and Jack Cush discuss autoinflammatory highlights from the Virtual EULAR 2020 meeting June 3-6

      These were my top abstracts from Thursday, 4th of June at EULAR 2020: Long Delays in Denosumab Increase Fracture Risk (SAT0453).  A UK population based study looked at risk of fracture in…
      These were my top abstracts from Thursday, 4th of June at EULAR 2020: Voclosporin Effective in Lupus Nephritis (OP0277). Voclosporin is a calcineurin inhibitor that has performed well in an…
      For a disease that has been recognized since the days of Hippocrates, we are finally making some progress towards understanding systemic lupus erythematosus (SLE) and how to tame the wolf. …
      Flares in ANCA-associated vasculitis are difficult to predict, but serum calprotectin may help predict relapse and renal failure, according to data presented at the EULAR 2020 virtual meeting this…
      These were my top abstracts from Thursday, 4th of June at EULAR 2020. TORTUGA Study (THU0377): Filgotinib in active axial spondyloarthritis patients.  TORTUGA enrolled 116 patients with AxSpA…
      GCA and Risk of Cancer or Visual Loss

      Dr. Olga Petryna from EULAR2020 Virtual Conference

      OP0149 Tocilizumab Treats Visual Loss in GCA

      OP0143 GCA in Israel and risk of Cancer

      Enticing New Options in ANCA-Associated Vasculitis

      Dr. David Liew from EULAR2020 ANCA-Associated Vasculitis Avacopan vs Prednisone MAINRITSAN 2 study - Calprotectin

      ×